phrykt

Teladoc Health, Inc. (TDOC): who owns it and who trades it

As of Nov 16, 2026, TDOC insiders reported 38 open-market sales worth $2.7M and no purchases in the last 12 months, with 29% of the sale value made under pre-set 10b5-1 plans. The largest seller was Charles Divita III (CEO), with $1M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Teladoc Health

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns TDOC

344 funds and institutions reported TDOC shares worth $1.3B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 9.0%.

Funds and institutions (13F) 86%Everyone else 14%

10 largest owners, by share of the company

BlackRock, Inc.9.0%
Vanguard Portfolio Management LLC7.0%
Point72 Asset Management, L.P.4.6%
Renaissance Technologies LLC4.5%
Voss Capital, LP4.5%
Vanguard Capital Management LLC4.4%
Dimensional Fund Advisors LP4.1%
State Street Corp2.7%
American Century Companies Inc2.7%
Allianz Asset Management GmbH2.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.16.22M8.99%$138M+11%
Vanguard Portfolio Management LLC12.69M7.03%$108M+3%
Point72 Asset Management, L.P.8.24M4.56%$69.9M+7%
Renaissance Technologies LLC8.07M4.47%$68.5M-0%
Voss Capital, LP8.05M4.46%$68.2M+92%
Vanguard Capital Management LLC7.96M4.41%$67.5M+1%
Dimensional Fund Advisors LP7.37M4.08%$62.5M+17%
State Street Corp4.96M2.75%$42.1M+14%
American Century Companies Inc4.89M2.71%$41.5M+42%
Allianz Asset Management GmbH4.67M2.59%$39.6M-3%
Geode Capital Management, LLC4.65M2.58%$39.5M+11%
Goldman Sachs Group Inc3.82M2.12%$32.4M+41%
Monaco Asset Management SAM3.17M1.75%$26.9M-21%
Jupiter Asset Management Ltd3.11M1.72%$26.4MNo change
Charles Schwab Investment Management Inc3.06M1.70%$26M+1%
Sixth Street Partners Management Company, L.P.3.06M1.70%$26M–
Quantinno Capital Management LP2.82M1.56%$23.9M+8%
Federated Hermes, Inc.2.13M1.18%$18M+25%
UBS Group AG2.05M1.14%$17.4M+19%
Arrowstreet Capital, Limited Partnership2.04M1.13%$17.3M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, TDOC insiders reported $0 of open-market purchases and $2.7M of sales. 29% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$2.7M
38 trades, 6 people
Sales under a 10b5-1 plan
29%
Share of sale value
Latest trade
Nov 6, 2026
Filed Nov 9, 2026

Purchases and sales by month

$1M$1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 6, 2026Carlos NuenoPresidentSale plan29,432$9.20$271KForm 4
Oct 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale655$5.65$3.7KForm 4
Sep 11, 2026Charles Divita IIICEOSale17,805$6.10$109KForm 4
Sep 3, 2026Fernando M. RodriguesPresidentSale plan9,812$6.51$63.9KForm 4
Sep 2, 2026Carlos NuenoPresidentSale6,200$6.30$39.1KForm 4
Sep 2, 2026Adam C VandervoortCHIEF LEGAL OFFICERSale7,573$6.30$47.7KForm 4
Sep 2, 2026Kelly BlissPresidentSale7,357$6.30$46.3KForm 4
Sep 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale274$6.30$1.7KForm 4
Sep 2, 2026Charles Divita IIICEOSale18,327$6.30$115KForm 4
Sep 2, 2026Fernando M. RodriguesPresidentSale plan5,439$6.30$34.3KForm 4
Jul 6, 2026Kelly BlissPresidentSale plan2,500$9.50$23.8KForm 4
Jul 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale653$9.10$5.9KForm 4
Jul 1, 2026Kelly BlissPresidentSale plan2,500$9.00$22.5KForm 4
Jun 29, 2026Kelly BlissPresidentSale plan2,500$8.50$21.2KForm 4
Jun 11, 2026Charles Divita IIICEOSale18,074$6.94$125KForm 4
Jun 3, 2026Fernando M. RodriguesPresidentSale plan9,572$7.40$70.8KForm 4
Jun 2, 2026Fernando M. RodriguesPresidentSale5,677$7.63$43.3KForm 4
Jun 2, 2026Adam C VandervoortCHIEF LEGAL OFFICERSale7,906$7.63$60.3KForm 4
Jun 2, 2026Carlos NuenoPresidentSale6,196$7.63$47.3KForm 4
Jun 2, 2026Charles Divita IIICEOSale19,132$7.63$146KForm 4
Jun 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale284$7.63$2.2KForm 4
Jun 2, 2026Kelly BlissPresidentSale7,679$7.63$58.6KForm 4
Apr 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale675$5.11$3.4KForm 4
Mar 11, 2026Charles Divita IIICEOSale27,731$5.49$152KForm 4
Mar 3, 2026Fernando M. RodriguesPresidentSale plan25,086$4.98$125KForm 4
Mar 2, 2026Adam C VandervoortCHIEF LEGAL OFFICERSale27,083$5.12$139KForm 4
Mar 2, 2026Carlos NuenoPresidentSale20,165$5.12$103KForm 4
Mar 2, 2026Fernando M. RodriguesPresidentSale plan16,314$5.12$83.5KForm 4
Mar 2, 2026Charles Divita IIICEOSale50,145$5.12$257KForm 4
Mar 2, 2026Joseph Ronald CatapanoChief Accounting OfficerSale1,333$5.12$6.8KForm 4
Mar 2, 2026Kelly BlissPresidentSale26,647$5.12$136KForm 4
Jan 5, 2026Joseph Ronald CatapanoChief Accounting OfficerSale758$7.15$5.4KForm 4
Dec 11, 2025Charles Divita IIICEOSale17,138$7.63$131KForm 4
Dec 3, 2025Fernando M. RodriguesPresidentSale plan4,209$7.48$31.5KForm 4
Dec 2, 2025Fernando M. RodriguesPresidentSale plan2,324$7.49$17.4KForm 4
Dec 2, 2025Adam C VandervoortCHIEF LEGAL OFFICERSale5,720$7.49$42.8KForm 4
Dec 2, 2025Carlos NuenoPresidentSale3,897$7.49$29.2KForm 4
Dec 2, 2025Kelly BlissPresidentSale4,582$7.49$34.3KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Charles Divita IIICHIEF EXECUTIVE OFFICER, Director–$1MSep 11, 2026
Carlos NuenoPresident, International–$490KNov 6, 2026
Fernando M. RodriguesPresident of BetterHelp–$470KSep 3, 2026
Kelly BlissPresident, U.S. Group Health–$343KSep 2, 2026
Adam C VandervoortCHIEF LEGAL OFFICER, SECRETARY–$290KSep 2, 2026
Joseph Ronald CatapanoChief Accounting Officer–$29.2KOct 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

TDOC short interest

High short interest. 17.7% of TDOC shares are sold short: about 1 share in 6. Over the last 12 reports the number of shares short went up 21%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 32.19M TDOC shares were sold short, 17.7% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 5.69M shares, buying them all back would take about 5.7 trading days (days to cover).

Shares short, % of all shares

17.7%May 15Oct 3018.4%

Days to cover

5.7May 15Oct 309.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202632.19M17.66%+0%5.69M5.7
Oct 15, 202632.07M17.65%+7%3.91M8.2
Sep 30, 202630.10M16.57%+9%3.37M8.9
Sep 15, 202627.63M15.21%+9%3.25M8.5
Aug 31, 202625.34M13.95%+7%3.53M7.2
Aug 14, 202623.69M13.04%-10%4.74M5.0
Jul 31, 202626.30M14.48%-6%6.65M4.0
Jul 15, 202628.06M15.54%+2%4.26M6.6
Jun 30, 202627.42M15.19%-7%4.79M5.7
Jun 15, 202629.44M16.31%+6%3.98M7.4
May 29, 202627.71M15.35%+5%4.40M6.3
May 15, 202626.51M14.69%-10%5.78M4.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Teladoc Health company events

Teladoc Health filed 14 reports on Form 8-K in the last 12 months, 9 of them about an important change (leadership). The latest was on Oct 28, 2026.

  1. Oct 28, 2026ResultsReleased financial results. Filing
  2. Sep 25, 2026LeadershipMr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc., informed the Company of his decision to resign, effective November 1, 2026. Filing
  3. Aug 31, 2026LeadershipTeladoc Health, Inc. hired Michael Grasher as its Chief Financial Officer. Filing
  4. Aug 13, 2026LeadershipMr. David B. Snow, Jr. notified Teladoc Health, Inc. of his intention to retire from the Board effective as of September 30, 2026. Filing
  5. Aug 3, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company. Filing
  6. Jul 29, 2026ResultsReleased financial results. Filing
  7. May 21, 2026VoteReported shareholder vote results. Filing
  8. Apr 29, 2026ResultsReleased financial results. Filing
  9. Mar 30, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to nine and appointed Susan R. Salka as a director of the Company. Filing
  10. Feb 25, 2026ResultsReleased financial results. Filing
  11. Feb 18, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to ten and appointed Michael S. Smith as a director of the Company. Filing
  12. Feb 12, 2026LeadershipMr. Thomas G. McKinley notified Teladoc Health, Inc. of his intention to retire from the Board effective as of February 20, 2026. Filing
  13. Dec 16, 2025LeadershipMr. J. Eric Evans notified Teladoc Health, Inc. of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders and to retire from the Board effective as of the conclusion of the Annual Meeting. Filing
  14. Dec 12, 2025LeadershipTeladoc Health, Inc. amended its 2023 Employment Inducement Incentive Award Plan (as amended, the “2023 Inducement Plan”) solely to increase the number of shares of common stock, par value $0.001 per share, reserved for issuance under the 2023 Inducement Plan by 1,780,000 shares, to a new total of… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Teladoc Health financials

Famous investors that hold TDOC

5 of the 50 well-known investors we track reported holding TDOC in their latest 13F filing. The largest position is Jim Simons's, worth $46.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20268.00M$46.4M0.1%-1%
Steve Cohen · Point72 Asset ManagementQ3 20267.95M$46.1M0.1%-3%
Israel Englander · Millennium ManagementQ3 2026317,351$1.8M0.0%+118%
Ken Griffin · Citadel AdvisorsQ3 202678,016$452K0.0%-90%
Ray Dalio · Bridgewater AssociatesQ3 202611,339$65.8K0.0%-4%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named TDOC in the last 120 days.

FiledHolderFormStake
Oct 8, 2026Dimensional Fund Advisors LP13G5.0%
Oct 8, 2026Dimensional Fund Advisors LP13G5.0%

Questions about Teladoc Health, Inc. (TDOC) stock

Who owns the most TDOC stock?

The largest reported owner of Teladoc Health, Inc. (TDOC) is BlackRock, Inc., with 9.0% of the company. In total, 344 funds and institutions reported holding TDOC at the end of Q2 2026, together about 86% of the shares. See the largest owners.

Are TDOC insiders buying or selling?

In the last 12 months, TDOC insiders reported no open-market purchases and 38 sales worth $2.7M. The latest trade was on Nov 6, 2026. See every trade.

What is the short interest in TDOC?

As of Oct 30, 2026, 32.19M TDOC shares were sold short, 17.7% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 5.69M shares, buying them all back would take about 5.7 trading days (days to cover). See the history.

Which famous investors hold TDOC?

5 of the 50 well-known investors we track reported TDOC in their latest 13F filing, including Jim Simons, Steve Cohen, Israel Englander. The largest position is worth $46.4M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.